BAXTER

Company Overview

Baxter provides healthcare products and solutions with a strong presence in North America, Europe, Asia-Pacific, Latin America, and the Middle East. It is particularly recognized for its comprehensive renal care portfolio, which encompasses both therapeutic products and medical devices for the management of chronic kidney disease (CKD). Its offerings cover the entire CKD care continuum, from hemodialysis and peritoneal dialysis machines to dialyzers, bloodline sets, consumables, and renal therapeutics for fluid management, electrolyte balance, and supportive care. These integrated solutions support patients with end-stage kidney disease and dialysis-dependent CKD, while enabling healthcare providers to deliver efficient, high-quality treatment. The renal care unit oversees CKD devices and therapies, including dialysis machines, consumables, and related services. The pharmaceutical and biopharmaceuticals segment focuses on intravenous therapies, parenteral nutrition, and specialty renal medications. Meanwhile, the hospital products and clinical nutrition unit supplies infusion systems, IV solutions, and clinical nutrition products that complement CKD management in both hospital and outpatient settings.

Baxter's geographical presence includes the U.S. and Canada, major European countries such as Germany, France, the United Kingdom, and Switzerland, Asia-Pacific nations including Japan, China, India, and Australia, as well as Latin America, the Middle East, and Africa.

Financial Highlights (FY 2025)

Company's Business Segments

• Medical Products and Therapies : Infusion Therapies and Technologies, Advanced Surgery
• Healthcare Systems and Technologies : Care and Connectivity Solutions, Front Line Care
• Pharmaceuticals : Injectables and Anesthesia, Drug Compounding
• Other : Other sales primarily represent revenues earned by certain of our Manufacturing facilities from Contract manufacturing activities, Royalty income under a business development arrangement.